Page 4 - Opaleye Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Opaleye management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Opaleye Management Today - Breaking & Trending Today

Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […] ....

Eton Pharmaceuticals Inc , Goldman Sachs Group Inc , Harrow Health , Nuveen Asset Management , Harrow Health Stock , Barclays Plc , Surface Ophthalmics Inc , Pricet Rowe Associates Inc , News Ratings For Harrow Health Daily , Vanguard Group Inc , Hedge Funds Weigh In On Harrow Health , Opaleye Management Inc , Harrow Health Inc , Pharmaceuticals Inc , Free Report , Sachs Group , Asset Management , Opaleye Management , Get Free Report , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Gap Up to $9.69

Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Gap Up to $9.69
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Arcutis Biotherapeutics , Opaleye Management Inc , Jennison Associates , Franklin Resources Inc , Needham Company , Arcutis Biotherapeutics Inc , Goldman Sachs Group , Vanguard Group Inc , Get Free Report , Point Capital , Opaleye Management ,

Ocular Therapeutix (OCUL) Announces $325M Private Placement at $7.52/sh

Ocular Therapeutix (OCUL) Announces $325M Private Placement at $7.52/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Ocular Therapeutix Inc , Great Point Partners , Exchange Commission , Ocular Therapeutix , Venrock Healthcare Capital Partners , Deep Track Capital , Perceptive Advisors , Logos Capital , Surveyor Capital , Acuta Capital Partners , Opaleye Management , Securities Act ,

Ocular Therapeutix, Inc. Announces $325.0 Million Private

BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) Ocular Therapeutix, Inc. (Nasdaq:OCUL) (the “Company”), a biopharmaceutical company committed to. ....

United States , Joyce Allaire , Donald Notman , Ocular Therapeutix Inc , Exchange Commission , Great Point Partners , Venrock Healthcare Capital Partners , Deep Track Capital , Perceptive Advisors , Logos Capital , Surveyor Capital , Acuta Capital Partners , Opaleye Management , Securities Act , Ocular Therapeutix , Looking Statements , Private Securities Litigation Reform Act , Nasdaq Ocul , Ocular Therapeutix ,

Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement

Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Joyce Allaire , Donald Notman , Ocular Therapeutix Inc , Great Point Partners , Exchange Commission , Venrock Healthcare Capital Partners , Deep Track Capital , Perceptive Advisors , Logos Capital , Surveyor Capital , Acuta Capital Partners , Opaleye Management , Securities Act , Ocular Therapeutix , Looking Statements , Private Securities Litigation Reform Act ,